The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival

Molecular and Cellular Biology

Volumn 29, Issue 10, 2009, Pages 2489-2504

  Barkić, Martina ^a   Crnomarković, Sladana ^a   Grabušić, Kristina ^a   Bogetić, Ivana ^a   Panić, Linda ^a   Tamarut, Sanda ^a   Cokarić, Maja ^a   Jerić, Ines ^a   Vidak, Sandra ^a   Volarević, Siniša ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

P21 ACTIVATED KINASE; PROTEIN P53; RIBOSOME PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; RIBOSOMAL PROTEIN L24; SMALL INTERFERING RNA;

ANIMAL TISSUE; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO MORTALITY; FEMALE; GENE ACTIVATION; GENE CONTROL; GENE FUNCTION; GENE SILENCING; GENETIC ASSOCIATION; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; ANIMAL EMBRYO; APOPTOSIS; C57BL MOUSE; EYE MALFORMATION; GENE EXPRESSION REGULATION; GENETICS; HAIR COLOR; HISTOLOGY; HUMAN; MALE; METABOLISM; MOUSE MUTANT; MUSCULOSKELETAL SYSTEM MALFORMATION; PHYSIOLOGY; PREGNANCY; RNA INTERFERENCE; SURVIVAL RATE;

MUS;

ANIMALS; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EMBRYO, MAMMALIAN; EYE ABNORMALITIES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HAIR COLOR; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCULOSKELETAL ABNORMALITIES; PHENOTYPE; PREGNANCY; RIBOSOMAL PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 66249142352     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01588-08     Document Type: Article

References (62)

1. Amsterdam, A., K. C. Sadler, K. Lai, S. Farrington, R. T. Bronson, J. A. Lees, and N. Hopkins. 2004. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2:E139.
2. Armstrong, J. F., M. H. Kaufman, D. J. Harrison, and A. R. Clarke. 1995. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5:931-936.
3. Bhat, K. P., K. Itahana, A. Jin, and Y. Zhang. 2004. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J. 23:2402-2412.
4. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
5. Budanov, A. V., and M. Karin. 2008. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134:451-460.
6. Budde, A., and I. Grummt. 1999. p53 represses ribosomal gene transcription. Oncogene 18:1119-1124.
7. Cmejla, R., J. Cmejlova, H. Handrkova, J. Petrak, and D. Pospisilova. 2007. Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia. Hum. Mutat. 28:1178-1182.
8. Copp, A. J., F. A. Brook, and H. J. Roberts. 1988. A cell-type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryos developing spinal neural tube defects. Development 104:285-295.
9. Draptchinskaia, N., P. Gustavsson, B. Andersson, M. Pettersson, T. N. Willig, I. Dianzani, S. Ball, G. Tchernia, J. Klar, H. Matsson, D. Tentler, N. Mohandas, B. Carlsson, and N. Dahl. 1999. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet. 21:169-175.
10. Dresios, J., I. L. Derkatch, S. W. Liebman, and D. Synetos. 2000. Yeast ribosomal protein L24 affects the kinetics of protein synthesis and ribosomal protein L39 improves translational accuracy, while mutants lacking both remain viable. Biochemistry 39:7236-7244.
11. Ebert, B. L., J. Pretz, J. Bosco, C. Y. Chang, P. Tamayo, N. Galili, A. Raza, D. E. Root, E. Attar, S. R. Ellis, and T. R. Golub. 2008. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 451:335-339.
12. Farrar, J. E., M. Nater, E. Caywood, M. A. McDevitt, J. Kowalski, C. M. Takemoto, C. C. Talbot, Jr., P. Meltzer, D. Esposito, A. H. Beggs, H. E. Schneider, A. Grabowska, S. E. Ball, E. Niewiadomska, C. A. Sieff, A. Vlachos, E. Atsidaftos, S. R. Ellis, J. M. Lipton, H. T. Gazda, and R. J. Arceci. 2008. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 112:1582-1592.
13. Fatica, A., and D. Tollervey. 2002. Making ribosomes. Curr. Opin. Cell Biol. 14:313-318.
14. Feng, Z., H. Zhang, A. J. Levine, and S. Jin. 2005. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. USA 102:8204-8209.
15. Ferreira-Cerca, S., G. Poll, P. E. Gleizes, H. Tschochner, and P. Milkereit. 2005. Roles of eukaryotic ribosomal proteins in maturation and transport of pre-18S rRNA and ribosome function. Mol. Cell 20:263-275.
16. Garcia-Cao, I., M. Garcia-Cao, J. Martin-Caballero, L. M. Criado, P. Klatt, J. M. Flores, J. C. Weill, M. A. Blasco, and M. Serrano. 2002. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21:6225-6235.
17. Gazda, H. T., A. Grabowska, L. B. Merida-Long, E. Latawiec, H. E. Schneider, J. M. Lipton, A. Vlachos, E. Atsidaftos, S. E. Ball, K. A. Orfali, E. Niewiadomska, L. Da Costa, G. Tchernia, C. Niemeyer, J. J. Meerpohl, J. Stahl, G. Schratt, B. Glader, K. Backer, C. Wong, D. G. Nathan, A. H. Beggs, and C. A. Sieff. 2006. Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am. J. Hum. Genet. 79:1110-1118.
18. Gazda, H. T., M. R. Sheen, A. Vlachos, V. Choesmel, M. F. O'Donohue, H. Schneider, N. Darras, C. Hasman, C. A. Sieff, P. E. Newburger, S. E. Ball, E. Niewiadomska, M. Matysiak, J. M. Zaucha, B. Glader, C. Niemeyer, J. J. Meerpohl, E. Atsidaftos, J. M. Lipton, P. E. Gleizes, and A. H. Beggs. 2008. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 83:769-780.
19. Gilbert, S. F. 2003. Developmental biology, 7th ed. Sinauer Associates, Inc., Sunderland, MA.
20. Gottlieb, E., R. Haffner, A. King, G. Asher, P. Gruss, P. Lonai, and M. Oren. 1997. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis. EMBO J. 16:1381-1390.
21. Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1-7.
22. Jones, N. C., M. L. Lynn, K. Gaudenz, D. Sakai, K. Aoto, J. P. Rey, E. F. Glynn, L. Ellington, C. Du, J. Dixon, M. J. Dixon, and P. A. Trainor. 2008. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat. Med. 14:125-133.
23. Komarov, P. G., E. A. Komarova, R. V. Kondratov, K. Christov-Tselkov, J. S. Coon, M. V. Chernov, and A. V. Gudkov. 1999. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285:1733-1737.
24. Komarova, E. A., M. V. Chernov, R. Franks, K. Wang, G. Armin, C. R. Zelnick, D. M. Chin, S. S. Bacus, G. R. Stark, and A. V. Gudkov. 1997. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 16:1391-1400.
25. Kruiswijk, T., R. J. Planta, and J. M. Krop. 1978. The course of the assembly of ribosomal subunits in yeast. Biochim. Biophys. Acta 517:378-389.
26. Lohrum, M. A., R. L. Ludwig, M. H. Kubbutat, M. Hanlon, and K. H. Vousden. 2003. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 3:577-587.
27. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
28. Marion, M. J., and C. Marion. 1987. Localization of ribosomal proteins on the surface of mammalian 60S ribosomal subunits by means of immobilized enzymes: correlation with chemical cross-linking data. Biochem. Biophys. Res. Commun. 149:1077-1083.
29. McGowan, K. A., J. Z. Li, C. Y. Park, V. Beaudry, H. K. Tabor, A. J. Sabnis, W. Zhang, H. Fuchs, M. H. de Angelis, R. M. Myers, L. D. Attardi, and G. S. Barsh. 2008. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat. Genet. 40:963-970.
30. Mendez-Vidal, C., M. T. Wilhelm, F. Hellborg, W. Qian, and K. G. Wiman. 2002. The p53-induced mouse zinc finger protein wig-1 binds double-stranded RNA with high affinity. Nucleic Acids Res. 30:1991-1996.
31. Nagy, A., M. Gertsenstein, K. Vintersten, and R. Behringer. 2003. Manipulating the mouse embryo: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Nikolaev, A. Y., M. Li, N. Puskas, J. Qin, and W. Gu. 2003. Parc: a cytoplasmic anchor for p53. Cell 112:29-40.
33. Nonn, L., R. R. Williams, R. P. Erickson, and G. Powis. 2003. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23:916-922.
34. Oliver, E. R., T. L. Saunders, S. A. Tarle, and T. Glaser. 2004. Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute. Development 131:3907-3920.
35. Page, D. C., R. Mosher, E. M. Simpson, E. M. Fisher, G. Mardon, J. Pollack, B. McGillivray, A. de la Chapelle, and L. G. Brown. 1987. The sex-determining region of the human Y chromosome encodes a finger protein. Cell 51:1091-1104.
36. Panic, L., J. Montagne, M. Cokaric, and S. Volarevic. 2007. S6-haploinsufficiency activates the p53 tumor suppressor. Cell Cycle 6:20-24.
37. Panic, L., S. Tamarut, M. Sticker-Jantscheff, M. Barkic, D. Solter, M. Uzelac, K. Grabusic, and S. Volarevic. 2006. Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol. Cell. Biol. 26:8880-8891.
38. Pestov, D. G., Z. Strezoska, and L. F. Lau. 2001. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G1/S transition. Mol. Cell. Biol. 21:4246-4255.
39. Ray, P. S., A. Arif, and P. L. Fox. 2007. Macromolecular complexes as depots for releasable regulatory proteins. Trends Biochem. Sci. 32:158-164.
40. Rice, D. S., Q. Tang, R. W. Williams, B. S. Harris, M. T. Davisson, and D. Goldowitz. 1997. Decreased retinal ganglion cell number and misdirected axon growth associated with fissure defects in Bst/+ mutant mice. Investig. Ophthalmol. Vis. Sci. 38:2112-2124.
41. Rubbi, C. P., and J. Milner. 2003. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 22:6068-6077.
42. Rudra, D., and J. R. Warner. 2004. What better measure than ribosome synthesis? Genes Dev. 18:2431-2436.
43. Ruggero, D., and P. P. Pandolfi. 2003. Does the ribosome translate cancer? Nat. Rev. Cancer 3:179-192.
44. Sah, V. P., L. D. Attardi, G. J. Mulligan, B. O. Williams, R. T. Bronson, and T. Jacks. 1995. A subset of p53-deficient embryos exhibit exencephaly. Nat. Genet. 10:175-180.
45. Saveanu, C., A. Namane, P. E. Gleizes, A. Lebreton, J. C. Rousselle, J. Noaillac-Depeyre, N. Gas, A. Jacquier, and M. Fromont-Racine. 2003. Sequential protein association with nascent 60S ribosomal particles. Mol. Cell. Biol. 23:4449-4460.
46. Schmid, P., A. Lorenz, H. Hameister, and M. Montenarh. 1991. Expression of p53 during mouse embryogenesis. Development 113:857-865.
47. Schmidt, E. V. 1999. The role of c-myc in cellular growth control. Oncogene 18:2988-2996.
48. 1-phase progression. Genes Dev. 13:1501-1512.
49. Spritz, R. A., S. A. Holmes, R. Ramesar, J. Greenberg, D. Curtis, and P. Beighton. 1992. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism. Am. J. Hum. Genet. 51:1058-1065.
50. Sulic, S., L. Panic, M. Barkic, M. Mercep, M. Uzelac, and S. Volarevic. 2005. Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev. 19:3070-3082.
51. Tang, Q., D. S. Rice, and D. Goldowitz. 1999. Disrupted retinal development in the embryonic belly spot and tail mutant mouse. Dev. Biol. 207:239-255.
52. WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res. 60:679-684.
53. Vogelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408:307-310.
54. Volarevic, S., M. J. Stewart, B. Ledermann, F. Zilberman, L. Terracciano, E. Montini, M. Grompe, S. C. Kozma, and G. Thomas. 2000. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 288:2045-2047.
55. Vousden, K. H., and X. Lu. 2002. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2:594-604.
56. Watson, K. L., K. D. Konrad, D. F. Woods, and P. J. Bryant. 1992. Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system. Proc. Natl. Acad. Sci. USA 89:11302-11306.
57. Wool, I. G. 1996. Extraribosomal functions of ribosomal proteins. Trends Biochem. Sci. 21:164-165.
58. Yuan, B., R. Latek, M. Hossbach, T. Tuschl, and F. Lewitter. 2004. siRNA Selection Server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 32:W130-W134.
59. Yuan, X., Y. Zhou, E. Casanova, M. Chai, E. Kiss, H. J. Grone, G. Schutz, and I. Grummt. 2005. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol. Cell 19:77-87.
60. Zhai, W., and L. Comai. 2000. Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol. Cell. Biol. 20:5930-5938.
61. Zhang, Y., G. W. Wolf, K. Bhat, A. Jin, T. Allio, W. A. Burkhart, and Y. Xiong. 2003. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell. Biol. 23:8902-8912.
62. 1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol. Cancer Res. 1:195-206.